Uncategorized

ORPHELIA Pharma announces the commercial launch of Kigabeq® in France

Orega Biotech

Gilles Alberici, CEO and Jeremy Bastid, COO, will participate to the J.P. Morgan 38th Annual Healthcare Conference to be held 13-16 January 2020 in San Francisco, California, USA

Happy new Year

initiative Octalfa wishes you a happy new year 2020

ORPHELIA Pharma announces Orphan Drug Designation granted by FDA for temozolomide in the treatment of neuroblastoma

Newsletter november 2019

It has been a busy year for our Endowment Fund and Corporate Foundation!

Two new projects supported by our Foundation

The 22th of november 2019, the board of directors of the Foundation Dominique & Tom Alberici decided to support “APPEL” and “le Gai-Rire”,

ORPHELIA Pharma announces the granting of the Marketing Authorisation for Ivozall® from the European Commission

Preclinical data of novel ICI combination with anti-PD1 or anti-CTLA4 therapies

ORPHELIA Pharma and Veriton Pharma execute a license and distribution agreement for Kigabeq® in the United Kingdom

ORPHELIA announces the appointment of Dr. Caroline Lemarchand as Chief Pharmaceutical Development Officer